Ambey Laboratories Ltd Stock Price Today (NSE: AMBEY)

Ambey Laboratories Ltd

25.00+0.00 (+0.00%)
Market Closed

Fundamental Score

...

Ambey Laboratories Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Ambey Laboratories Ltd share price today is 25.00, up +0.00% on NSE/BSE as of 19 June 2026. Ambey Laboratories Ltd (AMBEY) is a Small-cap company in the Pesticides & Agrochemicals sector with a market capitalisation of 112.38 (Cr). The 52-week high for AMBEY share price is 48.30 and the 52-week low is 17.50. At a P/E ratio of 25.31x, AMBEY is currently trading below its industry average P/E of 29.36x. The company has a Return on Equity (ROE) of 8.75% and a debt-to-equity ratio of 0.44.

Ambey Laboratories Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
37.30
Low
25.00
Volume
12.8K
Change
-28.67%

Ambey Laboratories Ltd share price chart: -28.67% return over the past month. 52-week high ₹48.30, 52-week low ₹17.50.

Ambey Laboratories Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
26.2526.2525.0025.004.00K (Cr)
28.3528.3526.2526.2518.00K (Cr)
26.0026.0025.7525.7516.00K (Cr)
27.1027.1027.1027.106.00K (Cr)
27.6528.1027.3028.1012.00K (Cr)
30.1030.1530.1030.154.00K (Cr)
31.5031.5029.9531.5012.00K (Cr)
35.4535.4534.8534.8526.00K (Cr)
37.2037.3036.8036.808.00K (Cr)
19.8020.4519.8020.258.00K (Cr)

Ambey Laboratories Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
31.5031.5025.0025.00-20.63%
19.8037.3019.8034.85+76.01%
22.0022.6017.5018.90-14.09%
30.5033.0027.5027.90-8.52%
40.6540.6531.0531.35-22.88%
44.0545.0539.0040.00-9.19%
40.0046.0031.0542.00+5.00%
40.0042.9539.2040.00+0.00%
40.4044.7540.0040.00-0.99%
48.3048.3038.0540.40-16.36%
39.0046.8037.5043.70+12.05%
37.5039.7031.8539.00+4.00%

AI Research Briefing

Powered by Gemini · 2026-04-17

Micro-cap agrochemical play with negative free cash flow and stretched working capital; avoid until financials improve.

Research Confidence
4.0/10Low
MICRO-CAP DARK HORSEConsolidation. 1M: 12.48%, 3M: 3.44%, 6M: 8.03%P/E of 25.31x vs Industry P/E of 29.36x, appears fair but quality of earnings is questionable given negative FCF.

WHAT'S HAPPENING NOW (last 2-4 weeks)

No major catalysts found after live search. Recent corporate announcements include updates and agreements, and a board meeting was held on January 12, 2026, to discuss items including a potential change of the company name.

CORE STORY (THE REAL GAME)

Why Now
  • Agrochemical market growth in India
  • Government support for modernizing agriculture
  • India emerging as a competitive export hub
Potential Catalysts
  • Significant order wins
  • Positive free cash flow generation
  • Reduction in working capital days
Key Risks
  • Micro/SME cap - liquidity risk
  • Negative free cash flow of ₹-52.92 Cr over the last 5 years
  • Increasing debtor days and working capital days
Institutional Activity

Promoter holding is high at 70.15%, with a slight increase of 0.04%. FII and DII holdings are minimal, with a decrease in both.

Macro Context

India's strong economic fundamentals cushion the blow of high crude prices, but GDP growth could slow if crude oil averages at $130 in 2026.

Cash Flow Quality

No. Free Cash Flow 5Y: ₹-52.92 Cr

3–6 Month Outlook

Ambey needs to demonstrate improved financial discipline and capitalize on the agrochemical market growth. Focus on FCF generation and working capital management is crucial.

Primary Thesis Risk

Inability to generate positive free cash flow will lead to collapse.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

8.75%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

9.97%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

8.92%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Ambey Laboratories Ltd Valuation Check

Good

Price to Earnings (P/E)

25.31x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

29.36x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

70.15%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

1.96%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-11.78%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

0.78%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Good

Debt to Equity Ratio

0.44x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

3.92x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-52.92 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Ambey Laboratories Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of AMBEY across key market metrics for learning purposes.

Positive Indicators

2 factors identified

Balanced Promoter Holding (70.15%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

6 factors identified

Below-Average Return on Equity (8.75%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (9.97%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Profit Decline Concern (-11.78%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Negative Free Cash Flow (₹-52.92 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 1.96%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Ambey Laboratories Ltd vs Pesticides & Agrochemicals Peers

Peer Comparison - Pesticides & Agrochemicals

Compare Ambey Laboratories Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
21.6/100
25
₹112.38
25.3
Average
8.75%
Poor
9.97%
Poor
0.4
Excellent
0.00%
UPL Ltd...
UPL512070
29.8/100
656
₹63303.75
26.7
Average
3.29%
Poor
7.66%
Poor
0.9
Good
-16.10%
Poor
5.46%
Good
0.80%
63.8/100
2847
₹51402.12
34.0
Average
17.61%
Good
22.86%
Excellent
0.0
Excellent
29.53%
Excellent
18.83%
Excellent
0.47%
51.9/100
496
₹23622.23
43.7
Average
18.81%
Good
25.14%
Excellent
0.0
Excellent
17.27%
Excellent
4.98%
Average
0.25%
46/100
4616
₹20761.67
34.1
Average
19.96%
Good
24.80%
Excellent
0.0
Excellent
-0.06%
Poor
8.68%
Good
2.71%
68.3/100
935
₹7868.22
17.4
Average
12.62%
Average
16.50%
Good
0.0
Excellent
8.25%
Good
16.62%
Excellent
1.03%
56.7/100
1180
₹5600.99
20.0
Average
21.95%
Excellent
28.29%
Excellent
0.0
Excellent
15.69%
Excellent
12.69%
Good
0.16%
28.4/100
251
₹5133.00
30.1
Average
6.65%
Poor
10.12%
Average
0.0
Excellent
-6.88%
Poor
3.41%
Average
0.95%
32.4/100
1489
₹4344.48
31.3
Average
11.09%
Average
14.33%
Average
0.1
Excellent
-6.27%
Poor
-0.71%
Poor
0.01%
0/100
161
₹3826.07
-25.75%
Poor
-7.80%
Poor
1.1
Average
4.00%
Average
0.00%
31.2/100
245
₹3163.13
259.5
Average
2.53%
Poor
5.19%
Poor
0.3
Excellent
22.42%
Excellent
12.39%
Good
0.06%

Ambey Laboratories Ltd Quarterly Performance

Latest quarterly metrics for AMBEY — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

0.78%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-11.78%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Ambey Laboratories Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for AMBEY — calculated from daily price history

43RSI 14
Neutral — RSI 43

Momentum is balanced — neither overbought nor oversold.

SMA 50
35
▼ Price below SMA 50 — Short-term bearish
SMA 200
39
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
25K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Ambey Laboratories Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Ambey Laboratories Ltd (AMBEY) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Ambey Laboratories Ltd

About AMBEY (Ambey Laboratories Ltd)

Ambey Laboratories Ltd (AMBEY) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pesticides & Agrochemicals secto...r with a current market capitalisation of ₹112.38 (Cr). Ambey Laboratories Ltd has delivered a Return on Equity (ROE) of 8.75% and a ROCE of 9.97%. The debt-to-equity ratio stands at 0.44, reflecting the company's capital structure. Investors tracking AMBEY share price can monitor key metrics including P/E ratio, promoter holding of 70.15%, and quarterly earnings growth.

Company Details

Symbol:AMBEY
Industry:Pesticides & Agrochemicals
Sector:Pesticides & Agrochemicals
Website:N/A

AMBEY Share Price: Frequently Asked Questions

What is the current share price of Ambey Laboratories Ltd?

Ambey Laboratories Ltd (AMBEY) trades at ₹25.00 on NSE. Market cap ₹112.38 (Cr). Educational data only.

What is the P/E ratio of Ambey Laboratories Ltd?

Ambey Laboratories Ltd has a P/E of 25.31x vs industry average 29.36x.

What is the Bull Run score for Ambey Laboratories Ltd?

Ambey Laboratories Ltd has a Bull Run score of 21.6/100 based on 25+ financial parameters.

Does Ambey Laboratories Ltd pay dividends?

Ambey Laboratories Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Ambey Laboratories Ltd?

Ambey Laboratories Ltd has ROE of 8.75%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Ambey Laboratories Ltd?

Ambey Laboratories Ltd has debt-to-equity of 0.44.

Is Ambey Laboratories Ltd a good investment?

Bull Run gives Ambey Laboratories Ltd a score of 21.6/100. This is not investment advice — consult a SEBI-registered advisor.